Mark Reale, Corporate Communications Manager,
Takeda UK
"The communications environment surrounding Mepact® has been challenging – the unprecedented situation of a cancer treatment for an ultra-orphan disease going through a NICE appraisal. Liberation became a crucial part of the brand team from the beginning, advising on all aspects of the communications strategy.
Due to the rarity of the disease there is a very small pool of expert and patient experience, however Liberation optimised this limited experience by working closely with the key patient and professional groups and medical opinion leaders. The excellent relationships that Liberation has helped us build have impacted hugely on key milestones within the communications programme. The team is dedicated and professional, and we look forward to achieving further successes with them in the future."
